A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection.

This study has been completed.

Study NCT00353418 Information provided by Hoffmann-La Roche

First Received: July 17, 2006 Last Updated: November 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2009
Estimated Primary Completion Date:	No date given